# Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

> **NCT01215474** · — · COMPLETED · sponsor: **Provitro GmbH** · enrollment: 500 (actual)

## Conditions studied

- Mutations in Exons 18 to 21

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01215474
- **Lead sponsor:** Provitro GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2011-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215474, "Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01215474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*